We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.73B
AUM Growth
-$641M
Cap. Flow
-$442M
Cap. Flow %
-11.83%
Top 10 Hldgs %
5.17%
Holding
1,489
New
168
Increased
277
Reduced
362
Closed
84

Top Sells

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$18.8M
2
WAT icon
Waters Corp
WAT
+$15.6M
3
CMI icon
Cummins
CMI
+$15.3M
4
CI icon
Cigna
CI
+$15.1M
5
AMP icon
Ameriprise Financial
AMP
+$13.2M

Sector Composition

Rank Sector Weight
1 Financials 27.38%
2 Energy 11.53%
3 Industrials 10.56%
4 Consumer Discretionary 10.28%
5 Technology 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FGNX
1351
FG Nexus Inc
FGNX
$41.1M
$49K ﹤0.01%
240
-264
-52% -$51.8K
JOB icon
1352
GEE Group
JOB
$22.7M
$49K ﹤0.01%
77,600
LSF icon
1353
Laird Superfood
LSF
$49.4M
$47K ﹤0.01%
26,000
-10,000
-28% -$22.1K
ENSV
1354
DELISTED
Enservco Corp.
ENSV
$47K ﹤0.01%
36,093
-20,000
-36% -$32.9K
PZG icon
1355
Paramount Gold Nevada
PZG
$123M
$46K ﹤0.01%
150,000
APTX
1356
DELISTED
Aptinyx Inc. Common Stock
APTX
$46K ﹤0.01%
124,041
-33,600
-21% -$16.8K
AMZE
1357
Amaze Holdings
AMZE
$1.46M
$44K ﹤0.01%
136
ARTW icon
1358
Arts-Way Manufacturing Co
ARTW
$11.4M
$43K ﹤0.01%
23,286
ESOA icon
1359
Energy Services of America
ESOA
$294M
$43K ﹤0.01%
15,000
CATX icon
1360
Perspective Therapeutics
CATX
$340M
$42K ﹤0.01%
18,400
UBX
1361
DELISTED
Unity Biotechnology
UBX
$42K ﹤0.01%
10,705
-8,440
-44% -$53.2K
BZFD icon
1362
BuzzFeed
BZFD
$94.9M
$39K ﹤0.01%
+6,250
New +$43K
FBRX icon
1363
Forte Biosciences
FBRX
$1.57B
$39K ﹤0.01%
1,475
-2,000
-58% -$63.5K
ELOX
1364
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$38K ﹤0.01%
5,623
-612
-10% -$7.36K
AMPE
1365
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$37K ﹤0.01%
2,023
PHAS
1366
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$35K ﹤0.01%
201,600
+75,000
+59% +$76.5K
BWEN icon
1367
Broadwind
BWEN
$111M
$33K ﹤0.01%
+10,792
New +$27.5K
QNGY
1368
DELISTED
Quanergy Systems, Inc.
QNGY
$33K ﹤0.01%
8,000
ECOR icon
1369
electroCore
ECOR
$71.9M
$32K ﹤0.01%
5,239
OGEN icon
1370
Oragenics
OGEN
$2.48M
$32K ﹤0.01%
78
TTOO
1371
DELISTED
T2 Biosystems, Inc
TTOO
$32K ﹤0.01%
57
RNAC icon
1372
Cartesian Therapeutics
RNAC
$262M
$31K ﹤0.01%
+640
New +$35.2K
IGC icon
1373
IGC Pharma
IGC
$26.6M
$30K ﹤0.01%
69,000
-70,000
-50% -$37.3K
TRML
1374
DELISTED
Tourmaline Bio
TRML
$30K ﹤0.01%
+1,150
New +$41.9K
OMIC
1375
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$30K ﹤0.01%
397
-53
-12% -$5.54K

Similar funds

Bridgeway Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Bridgeway Capital Management held 1,489 positions worth $3.73B, down 15% from $4.38B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Bridgeway Capital Management withdrew a net $442M in Q3 2022, closing 84 positions and reducing 362 holdings. Its most notable exit was L3Harris, an estimated $18.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in Cleveland-Cliffs worth $11M.

  • Bridgeway Capital Management's largest Q3 2022 buy was Cleveland-Cliffs: 819,000 shares worth $11M.
  • Bridgeway Capital Management added most to Meta Platforms (Facebook) in Q3 2022, an estimated $13.9M increase.
  • Bridgeway Capital Management's biggest Q3 2022 reduction was Waters Corp, cutting an estimated $15.6M.
  • Bridgeway Capital Management fully exited L3Harris in Q3 2022, selling an estimated $18.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.2% of its $3.73B portfolio in Q3 2022.
  • Bridgeway Capital Management opened 168 new positions and closed 84 in Q3 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $3.73B.

Based on Bridgeway Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.